Denali Capital Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
![Denali Capital Acquisition Corp - Ordinary Shares logo](/files/LOGO/1913577-DECA.png)
Company profile
Ticker
DECA
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
DECA stock data
Latest filings (excl ownership)
8-K
Changes in Registrant's Certifying Accountant
17 Jul 24
425
Business combination disclosure
10 Jul 24
8-K
Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination
10 Jul 24
8-K
Regulation FD Disclosure
5 Jul 24
DEF 14A
Definitive proxy
28 Jun 24
8-K
Denali Capital Acquisition Corp. and Longevity Biomedical, Inc. Mutually Agreed to Terminate the Business Combination
27 Jun 24
PRE 14A
Preliminary proxy
18 Jun 24
10-Q
2024 Q1
Quarterly report
21 May 24
NT 10-Q
Notice of late quarterly filing
15 May 24
10-K
2023 FY
Annual report
1 Apr 24
Latest ownership filings
SC 13G/A
Shaolin Capital Management LLC
22 Feb 24
SC 13G
GLAZER CAPITAL, LLC
14 Feb 24
SC 13G
CALAMOS INVESTMENT TRUST/IL
14 Feb 24
SC 13G/A
ATW SPAC MANAGEMENT LLC
13 Feb 24
SC 13G/A
BOOTHBAY FUND MANAGEMENT, LLC
13 Feb 24
SC 13G/A
Polar Asset Management Partners Inc.
13 Feb 24
SC 13G/A
Hudson Bay Capital Management LP
2 Feb 24
SC 13G
METEORA CAPITAL, LLC
7 Nov 23
SC 13G
Denali Capital Global Investments LLC
16 May 23
SC 13G
ATW SPAC MANAGEMENT LLC
14 Feb 23
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.01 k | 1.01 k | 1.01 k | 1.01 k | 1.01 k | 1.01 k |
Cash burn (monthly) | 67.82 k | 48.19 k | 122.75 k | 135.03 k | 124.72 k | 63.88 k |
Cash used (since last report) | 262.19 k | 186.33 k | 474.56 k | 522.03 k | 482.17 k | 246.96 k |
Cash remaining | -261.17 k | -185.31 k | -473.55 k | -521.02 k | -481.15 k | -245.95 k |
Runway (months of cash) | -3.9 | -3.8 | -3.9 | -3.9 | -3.9 | -3.9 |
Institutional ownership, Q1 2024
93.1% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 7 |
Opened positions | 4 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 4.01 bn |
Total shares | 4.70 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Denali Capital Global Investments | 2.44 mm | $0.00 |
Calamos Advisors | 700.00 k | $3.88 bn |
Context Capital Management | 605.00 k | $30.86 mm |
MFG Mizuho Financial | 493.67 k | $0.00 |
Feis Lawrence Michael | 255.02 k | $2.64 mm |
Cowen And | 195.72 k | $9.98 mm |
Dakota Wealth Management | 10.00 k | $87.48 mm |
Proequities | 0.00 | $0.00 |
Press releases
Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination
10 Jul 24
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination
2 Jul 24
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
11 Jun 24
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination
10 May 24